Vaccines represent one of the most crucial public health advances in human history. However, the discovery, development, and manufacturing of prophylactic and therapeutic vaccines to protect people against infectious and other diseases remains very challenging.
The Genedata Platform has been designed to increase the efficiency and quality of vaccine research, development, and manufacturing. The end-to-end enterprise platform supports the full discovery and development process for novel vaccines and enables faster and better testing, simplified production, and reduced costs. It supports not only classical vaccine R&D approaches, but also novel vaccine technologies such as synthetic self-amplifying mRNA and other innovative vaccine R&D techniques, accelerating the development of novel vaccines.
The Genedata Platform is a dedicated, purpose-built enterprise software system that accelerates vaccine discovery and development, automates complex R&D processes, supports teamwork in a division of labor environment, and integrates new R&D technologies and workflows. In particular, it supports:
Novel protein- and peptide-based subunit vaccine design
Innovative DNA and RNA vaccine engineering (e.g., self-amplifying messenger RNA)
Novel adjuvants discovery (e.g., via HT screening of immuno-potentiators)
Vaccine bioprocess development, including USP and DSP, formulation
High-throughput R&D processes (e.g., systematic use of scale-down bioreactors)
Automation and robotics integration (e.g., high-throughput formulation screening)
Novel technologies (e.g., polysaccharide vaccines, GMMA)
Presentation and delivery (e.g., alpha-virus vectors, vaccinia or baculovirus vectors)
Innate immune trigger identification
Biosafety assessment (e.g., NGS-based screens for adventitious agents)
Support of synthetic and cell-free processes
Reverse vaccinology based on whole-genome analysis of the pathogen
Bioconjugates management and testing
Cancer vaccine discovery
To find out how Genedata can help increase the efficiency and quality of your vaccine research, development, and manufacturing, email firstname.lastname@example.org.